Form 4: Fate Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Bahram Valamehr, President and CEO and a Director of Fate Therapeutics Inc, sold 43,947 shares of common stock on August 4, 2026 for $2.46 per share.
Summary
- Open-market sale: disposed of 43,947 Common Stock at $2.46 ($108,101) on August 4, 2026; holds 591,815 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $108,101 of stock on the open market.
Insider Transactions
Bahram Valamehr — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Open-market sale | Common Stock | 43,947 | $2 | $108.1K | 591,815 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Open-market sale (43,947 shares) |
Keywords
insider transaction, Form 4, FATE, FATE THERAPEUTICS INC, bearish, Bahram Valamehr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.